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  The serum sialic acid concentration ・in 17 male healthy adults， ll patients with acute
pros亡atitis and 12 patien亡s．w丘町acute epididym掘s「was measured w三th a spe¢ific enzymatic
assaykit． The concentration was studied in reLation to erythrocyte sedimentation rate， totpl’
serum protein and its fraction， C－reactive protein， hnd white blood cell’count． Blood sam－
ples were obtained from the patients immediately before antimicrobial chemotherapy and the
subsequent 3，・ 5， 7， 14， and’ 28 days． The ’ 垂窒?狽窒?≠狽高?獅?sialic acid con6etitration in the
patients was signific4ntly greater than that in the control subjects （P＞O．OOI）． The mean
serum sialic acid concentration in the patients reached a rnaximum level 3 days after the
beginning of the treatment，． and then gradually decreased． There was a significant corre－
lation between the daily change of the serum sialic acid level and those・ of the erythocyte
sedimentation rate， cr2－globulin， and ai－globulin． Serum sialic acid proved to be a useful
biochemical marker iR acute prostatitis and acute epididymitis．
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Fig． 1． Sialic acid levels in sera of
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F；g． 2． Sialic acid levels in sera of patients with acute prostatitis or
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Ng． 3， Erythrocyte sedimentation rates in patients with acute prostatitis
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Fig．4． α1－Globulin levels in sera of patients． with acute prostatitis or
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Fig．5．α2－Globulin．levels in sera of patients with acute prostatitis or
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Fig． 6． C－reactive protein （CRP） levels i．ri sera of patients 一with acute
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Fig． 7． White blood cell counts in patients with acute prostatitis or
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